Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug design.
Olusola Olalekan ElekofehintiOpeyemi IwaloyeFemi OlawaleProsper Obed ChukwuemekaIbukun Mary FolorunsoPublished in: In silico pharmacology (2021)
The online version contains supplementary material available at 10.1007/s40203-021-00108-8.